Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03392090 · ClinicalTrials.gov registry record · NA
SHARE (Sharing Goals and Preferences) Study
A NA study, sponsored by Dana-Farber Cancer Institute.
- Completed
- Registry status
- NA
- Development phase
- 53
- Enrollment target
NCT03392090 is a NA study that has completed, run by Dana-Farber Cancer Institute. The registered enrollment target is 53 participants.
The verdict
NCT03392090, a NA study, has completed, sponsored by Dana-Farber Cancer Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 53 participants
- Enrollment target
Study Summary
This research study is evaluating the usefulness of a video and questionnaire to help cancer patients think about the goals of their care.
Interventions
- OTHER More Good Days video&brief questionnaire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2018-07-23 |
| Est. Completion | 2022-03-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03392090
The ClinicalTrials.gov registry entry for NCT03392090 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which More Good Days video&brief questionnaire is the first listed.
NCT03392090 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03392090 about?
NCT03392090 is a clinical study titled "SHARE (Sharing Goals and Preferences) Study". This research study is evaluating the usefulness of a video and questionnaire to help cancer patients think about the goals of their care.
What is the current status of trial NCT03392090?
This trial is currently completed. It is a NA study. The enrollment target is 53 participants. The study started on 2018-07-23. Estimated completion is 2022-03-15.
What interventions are being tested in trial NCT03392090?
The interventions under investigation include: More Good Days video&brief questionnaire (OTHER).
Who is sponsoring clinical trial NCT03392090?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.